The partners will try to validate the Immray PanCan-d array-based test, which looks at proteins associated with the immune response to pancreatic cancer.
The company plans to offer the immuno-MRM assays as kits covering sample prep and protein digestion as well as immuno-enrichment of specific peptides.
The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.
Fluidic Analytics, a Cambridge University spinout, has licensed the technology and plans to commercialize an instrument for the research market in mid-2016.
The UK firm provides chemicals for DNA-, RNA-, and PCR-based research, products for DNA and protein labeling, and proteomics reagents and kits.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.
Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.
Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.
Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.